These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9013973)

  • 1. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
    Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
    Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation.
    Dentelli P; Del Sorbo L; Rosso A; Molinar A; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
    J Immunol; 1999 Aug; 163(4):2151-9. PubMed ID: 10438956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
    Barthomeuf C; Lamy S; Blanchette M; Boivin D; Gingras D; Béliveau R
    Free Radic Biol Med; 2006 Feb; 40(4):581-90. PubMed ID: 16458188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line.
    Fallani A; Calorini L; Mannini A; Gabellieri S; Mugnai G; Ruggieri S
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):171-7. PubMed ID: 17085325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
    Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-induced biphasic inositol 1,4,5-trisphosphate response and tyrosine phosphorylation of 140-kilodalton protein in mouse peritoneal macrophages.
    Shinji H; Akagawa KS; Tsuji M; Maeda M; Yamada R; Matsuura K; Yamamoto S; Yoshida T
    J Immunol; 1997 Feb; 158(3):1370-6. PubMed ID: 9013981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A; Tahraoui L; Sedivy P; Cavero I
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction.
    Russo S; Bussolati B; Deambrosis I; Mariano F; Camussi G
    J Immunol; 2003 Nov; 171(10):5489-97. PubMed ID: 14607955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
    Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
    J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.